Durasphere Post-Approval Studies Should Focus On Subgroups - FDA Panel

Advanced UroScience is anticipating a worldwide launch of the injectable bulking agent Durasphere sometime in the fourth quarter, following an approvable recommendation from FDA's Gastroenterology and Urology Devices Panel at its July 29 meeting in Rockville, Maryland.